Systemic silencing of PHD2 causes reversible immune regulatory dysfunction

Research output: Contribution to journalArticle

Authors

  • Atsushi Yamamoto
  • Joanna Hester
  • Philip S Macklin
  • Kento Kawai
  • Masateru Uchiyama
  • Daniel Biggs
  • Tammie Bishop
  • Katherine Bull
  • Xiaotong Cheng
  • Eleanor Cawthorne
  • Tanya L Crockford
  • Ben Davies
  • Lukas E Dow
  • Rob Goldin
  • Kamil Kranc
  • Hiromi Kudo
  • Hannah Lawson
  • James McAuliffe
  • Kate Milward
  • Cheryl L Scudamore
  • Elizabeth Soilleux
  • Fadi Issa
  • Peter J Ratcliffe
  • Chris W Pugh

Colleges, School and Institutes

Abstract

Physiological effects of cellular hypoxia are sensed by prolyl hydroxylase (PHD) enzymes, which regulate HIFs. Genetic interventions on HIF/PHD pathways have revealed multiple phenotypes that extend the known biology of hypoxia. Recent studies have unexpectedly implicated HIF in aspects of multiple immune and inflammatory pathways. However, such studies are often limited by systemic lethal effects and/or use tissue-specific recombination systems, which are inherently irreversible, unphysiologically restricted, and difficult to time. To study these processes better, we developed recombinant mice that expressed tetracycline-regulated shRNAs broadly targeting the main components of the HIF/ PHD pathway, permitting timed bidirectional intervention. We show that stabilization of HIF levels in adult mice through PHD2 enzyme silencing by RNA interference or inducible recombination of floxed alleles results in multilineage leukocytosis and features of autoimmunity. This phenotype was rapidly normalized on reestablishment of the hypoxia-sensing machinery when shRNA expression was discontinued. In both situations, these effects were mediated principally through the Hif2a isoform. Assessment of cells bearing Treg markers from these mice revealed defective function and proinflammatory effects in vivo. We believe our findings reveal a new role for the PHD2/HIF2α pathway in the reversible regulation of T cell and immune activity.

Details

Original languageEnglish
Article number124099
Pages (from-to)3640-3656
Number of pages17
JournalJournal of Clinical Investigation
Volume129
Issue number9
Early online date4 Jun 2019
Publication statusPublished - 3 Sep 2019